141 related articles for article (PubMed ID: 24093851)
1. Use of aldosterone antagonists at discharge after myocardial infarction: results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get with the Guidelines (GWTG).
Rao KK; Enriquez JR; de Lemos JA; Alexander KP; Chen AY; McGuire DK; Fonarow GC; Das SR
Am Heart J; 2013 Oct; 166(4):709-15. PubMed ID: 24093851
[TBL] [Abstract][Full Text] [Related]
2. Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction.
Rassi AN; Cavender MA; Fonarow GC; Cannon CP; Hernandez AF; Peterson ED; Peacock WF; Laskey WK; Rosas SE; Zhao X; Schwamm LH; Bhatt DL
J Am Coll Cardiol; 2013 Jan; 61(1):35-40. PubMed ID: 23137936
[TBL] [Abstract][Full Text] [Related]
3. Gender differences in time to presentation for myocardial infarction before and after a national women's cardiovascular awareness campaign: a temporal analysis from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation (CRUSADE) and the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get with the Guidelines (NCDR ACTION Registry-GWTG).
Diercks DB; Owen KP; Kontos MC; Blomkalns A; Chen AY; Miller C; Wiviott S; Peterson ED
Am Heart J; 2010 Jul; 160(1):80-87.e3. PubMed ID: 20598976
[TBL] [Abstract][Full Text] [Related]
4. Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure.
Curtis LH; Mi X; Qualls LG; Check DK; Hammill BG; Hammill SC; Heidenreich PA; Masoudi FA; Setoguchi S; Hernandez AF; Fonarow GC
Am Heart J; 2013 Jun; 165(6):979-986.e1. PubMed ID: 23708170
[TBL] [Abstract][Full Text] [Related]
5. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.
Lee JH; Yang DH; Park HS; Cho Y; Jeong MH; Kim YJ; Kim KS; Hur SH; Seong IW; Hong TJ; Cho MC; Kim CJ; Jun JE; Park WH; Chae SC;
Am Heart J; 2010 Jun; 159(6):1012-9. PubMed ID: 20569714
[TBL] [Abstract][Full Text] [Related]
6. Risk of heart failure complication during hospitalization for acute myocardial infarction in a contemporary population: insights from the National Cardiovascular Data ACTION Registry.
Shah RV; Holmes D; Anderson M; Wang TY; Kontos MC; Wiviott SD; Scirica BM
Circ Heart Fail; 2012 Nov; 5(6):693-702. PubMed ID: 23051950
[TBL] [Abstract][Full Text] [Related]
7. Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarction.
Somma KA; Bhatt DL; Fonarow GC; Cannon CP; Cox M; Laskey W; Peacock WF; Hernandez AF; Peterson ED; Schwamm L; Saxon LA
Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):654-61. PubMed ID: 22949493
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular ejection fraction assessment among patients with acute myocardial infarction and its association with hospital quality of care and evidence-based therapy use.
Miller AL; Dib C; Li L; Chen AY; Amsterdam E; Funk M; Saucedo JF; Wang TY
Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):662-71. PubMed ID: 22949495
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and Safety of Aldosterone Antagonist Therapy Use Among Older Patients With Reduced Ejection Fraction After Acute Myocardial Infarction.
Wang TY; Vora AN; Peng SA; Fonarow GC; Das S; de Lemos JA; Peterson ED
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26796254
[TBL] [Abstract][Full Text] [Related]
10. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.
Shah B; Hernandez AF; Liang L; Al-Khatib SM; Yancy CW; Fonarow GC; Peterson ED;
J Am Coll Cardiol; 2009 Feb; 53(5):416-22. PubMed ID: 19179199
[TBL] [Abstract][Full Text] [Related]
11. Contemporary patterns of discharge aspirin dosing after acute myocardial infarction in the United States: results from the National Cardiovascular Data Registry (NCDR).
Hall HM; de Lemos JA; Enriquez JR; McGuire DK; Peng SA; Alexander KP; Roe MT; Desai N; Wiviott SD; Das SR
Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):701-7. PubMed ID: 25116897
[TBL] [Abstract][Full Text] [Related]
12. Use of aldosterone antagonists in heart failure.
Albert NM; Yancy CW; Liang L; Zhao X; Hernandez AF; Peterson ED; Cannon CP; Fonarow GC
JAMA; 2009 Oct; 302(15):1658-65. PubMed ID: 19843900
[TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid receptor antagonist use in eligible patients following acute myocardial infarction: real world data from the Acute Coronary Syndrome Israeli Surveys: 2004-2010.
Koifman E; Kopel E; Maor E; Fefer P; Matezky S; Tofler G; Hamdan A; Grossman E; Goldenberg I; Klempfner R
Int J Cardiol; 2013 Oct; 168(4):3971-6. PubMed ID: 23890866
[TBL] [Abstract][Full Text] [Related]
14. Risk adjustment for in-hospital mortality of contemporary patients with acute myocardial infarction: the acute coronary treatment and intervention outcomes network (ACTION) registry-get with the guidelines (GWTG) acute myocardial infarction mortality model and risk score.
Chin CT; Chen AY; Wang TY; Alexander KP; Mathews R; Rumsfeld JS; Cannon CP; Fonarow GC; Peterson ED; Roe MT
Am Heart J; 2011 Jan; 161(1):113-122.e2. PubMed ID: 21167342
[TBL] [Abstract][Full Text] [Related]
15. Use of renin-angiotensin system blockers in acute coronary syndromes: findings from Get With the Guidelines-Coronary Artery Disease Program.
Bainey KR; Armstrong PW; Fonarow GC; Cannon CP; Hernandez AF; Peterson ED; Peacock WF; Laskey WK; Zhao X; Schwamm LH; Bhatt DL
Circ Cardiovasc Qual Outcomes; 2014 Mar; 7(2):227-35. PubMed ID: 24569634
[TBL] [Abstract][Full Text] [Related]
16. Characteristics, management, and outcomes of cocaine-positive patients with acute coronary syndrome (from the National Cardiovascular Data Registry).
Gupta N; Washam JB; Mountantonakis SE; Li S; Roe MT; de Lemos JA; Arora R
Am J Cardiol; 2014 Mar; 113(5):749-56. PubMed ID: 24388623
[TBL] [Abstract][Full Text] [Related]
17. Heart failure medications prescribed at discharge for patients with left ventricular assist devices.
Shreibati JB; Sheng S; Fonarow GC; DeVore AD; Yancy CW; Bhatt DL; Schulte P; Peterson ED; Hernandez A; Heidenreich PA
Am Heart J; 2016 Sep; 179():99-106. PubMed ID: 27595684
[TBL] [Abstract][Full Text] [Related]
18. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
[TBL] [Abstract][Full Text] [Related]
19. Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: data from the national registry of myocardial infarction.
Gore MO; Patel MJ; Kosiborod M; Parsons LS; Khera A; de Lemos JA; Rogers WJ; Peterson ED; Canto JC; McGuire DK;
Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):791-7. PubMed ID: 23132330
[TBL] [Abstract][Full Text] [Related]
20. Temporal changes in the use of drug-eluting stents for patients with non-ST-Segment-elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the can rapid risk stratification of unstable angina patients supress ADverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) and acute coronary treatment and intervention outcomes network-get with the guidelines (ACTION-GWTG) registries.
Roe MT; Chen AY; Cannon CP; Rao S; Rumsfeld J; Magid DJ; Brindis R; Klein LW; Gibler WB; Ohman EM; Peterson ED;
Circ Cardiovasc Qual Outcomes; 2009 Sep; 2(5):414-20. PubMed ID: 20031871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
